Author:
Foldvari M.,Oguejiofor C. J. N.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference28 articles.
1. Mizushima Y., Yanagawa A., Hoshi K. (1983): Prostaglandin E1 is more effective, when incorporated in lipid microspheres, for treatment of peripheral vascular diseases in man. J. Pharm. Pharmacol., 35, 666–667.
2. Peskar B.A., Hesse W.H., Rogatti W. et al. (1991): Formation of 13, 14-dihydroprostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease. Prostaglandins, 41, 225–228.
3. Virag R., Adaikan P.G. (1987): Effects of prostaglandin E1 on penile erection and erectile failure. J. Urol., 137, 1010.
4. Godschalk M.F., Chen J., Katz P.G., Mulligan T. (1994): Treatment of erectile failure with prostaglandin E1: a double-blind, placebo-controlled, dose-response study. J. Urol., 151, 1530–1532.
5. Ishii N., Watanabe H., Irisawa C. et al. (1986): Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence. Nippon Hinyokika Gakkai Zasshi, 77, 954–962.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献